Sonio, a Paris, France-based startup created in 2020 and developing artificial intelligence software that empowers fetal medicine professionals to secure pregnancy care, announced that it raised €5 million in funding.
The round was led by Elaia, alongside OneRagtime and Bpifrance.
The funding will allow Sonio to accelerate its entry into the U.S. and get FDA clearance, ramp up sales in Europe and add embedded image recognition into its platform.
Company: Sonio SAS
Funding Month: June 2022
Lead Investors: Elaia
Additional Investors: OneRagtime and Bpifrance
Company Website: https://sonio.ai/en/
Software Category: Pregnancy Care
About the Company: Founded in 2020, Sonio is the only SaaS platform that empowers healthcare professionals to secure prenatal care by combining technological innovation, medical expertise, and collective intelligence. It provides a unique Artificial Intelligence software that associates the knowledge of prenatal medicine practitioners with all types of medical, imaging, genetic, and environmental data to optimize prenatal screening and diagnosis. Sonio aims to improve access and quality of care for pregnant women and children. It is currently being used by 150 healthcare professionals in Europe. The Sonio team is supported daily by a team of doctors and midwives in France and Europe. The products are built in collaboration with doctors and midwives, to be as close as possible to their needs. Sonio believes in collective intelligence to develop the best products for fetal ultrasound.